Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy

Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy

Background: Intact immune responses to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) represent a biologically and clinically relevant correlate of ‘immunological fitness’ in humans. However, there is a lack of knowledge concerning anti-EBV or anti-CMV responses in patients with pulmonary tuberc...

Full description

Bibliographic Details
Main Authors:	Tumaini Nagu, Said Aboud, Martin Rao, Mecky Matee, Rebecca Axelsson, Davide Valentini, Ferdinand Mugusi, Alimuddin Zumla, Markus Maeurer
Format:	Article
Language:	English
Published:	Elsevier 2017-03-01
Series:	International Journal of Infectious Diseases
Subjects:	pulmonary tuberculosis EBV CMV cellular immune response IFN-γ survival TB therapy,
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971217300255

Similar Items

Infectious mononucleosis-like syndrome with high lymphocytosis and positive IgM EBV and CMV antibodies in a three-year-old girl
by: Joanna Alicja Krupka, et al.
Published: (2017-08-01)

Relationship of the recurrence after pterygium surgery with the presence of HSV, EBV, CMV, HPV, and BRAFV600E mutation
by: S.O. Rykov, et al.
Published: (2019-02-01)

Prevalence of Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) Subclinical Infection in Patients with Acute Immune Thrombocytopenic Purpura (ITP)
by: Farshad Abbasi, et al.
Published: (2021-07-01)

Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts
by: Regina Gary, et al.
Published: (2018-05-01)

Interactions of TTV with BKV, CMV, EBV, and HHV-6A and their impact on post-transplant graft function in kidney transplant recipients
by: Kamil S. Rosiewicz, et al.
Published: (2024-06-01)

CMV and EBV Co-Infection in HIV-Infected Children: Infection Rates and Analysis of Differential Expression of Cytokines in HIV Mono- and HIV–CMV–EBV Co-Infected Groups
by: Fizza Nazim, et al.
Published: (2022-08-01)

Epidemiology and Risk Factors for Viral Infections in Pediatric Liver Transplant Recipients and Impact on Outcome
by: Hala Abdullatif, et al.
Published: (2023-04-01)

Revisiting the Role of γδ T Cells in Anti-CMV Immune Response after Transplantation
by: Ahmed Gaballa, et al.
Published: (2021-05-01)

Correlation of Interleukin-10 and Interleukin-8 with Cytomegalovirus and Epstein–Barr Virus Infection in Hemodialysis Patients
by: Eman Ammar Ihsan, et al.
Published: (2024-10-01)

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study
by: Armin Gerbitz, et al.
Published: (2023-10-01)

Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation
by: Shan-shan Li, et al.
Published: (2022-03-01)

Molecular diagnostic of cytomegalovirus, Epstein Barr virus and Herpes virus 6 infections among blood donors by multiplex real-time PCR in Ouagadougou, Burkina Faso
by: Lassina Traore, et al.
Published: (2016-08-01)

Beyond Awareness: Hope for a CMV Vaccine! An Introduction to the Conference, “CMV Vaccine Development—How Close Are We?” (27–28 September 2023)
by: Megan H. Pesch, et al.
Published: (2024-10-01)

The Role of Cytomegalovirus, Haemophilus Influenzae and Epstein Barr Virus in Guillain Barre Syndrome
by: Shahriar Nafissi, et al.
Published: (2013-06-01)

The Role of Cytomegalovirus, Haemophilus Influenzae and Epstein Barr Virus in Guillain Barre Syndrome
by: Shahriar Nafissi, et al.
Published: (2013-06-01)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
by: Qiuting Zhang, et al.
Published: (2023-09-01)

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
by: Marija Rozman, et al.
Published: (2022-07-01)

From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity
by: Darja Kanduc, et al.
Published: (2020-08-01)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
by: James P. Dugan, et al.
Published: (2019-03-01)

Genotypes of Epstein–Barr virus (EBV1/EBV2) in individuals with infectious mononucleosis in the metropolitan area of Belém, Brazil, between 2005 and 2016
by: Talita Antonia Furtado Monteiro, et al.
Published: (2020-07-01)

Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
by: Lorenza Torti, et al.
Published: (2012-01-01)

Proceedings of the Conference “CMV Vaccine Development—How Close Are We?” (27–28 September 2023)
by: Mark R. Schleiss, et al.
Published: (2024-10-01)

Epstein–Barr virus and cytomegalovirus coinfection in Egyptian COVID-19 patients
by: Eman F Barakat, et al.
Published: (2023-05-01)

Development and Assessment of a Prenatal Cytomegalovirus (CMV) Educational Survey: Implementation and Impact in a Metropolitan University-Based Clinic
by: Schaefer MR, et al.
Published: (2020-12-01)

Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine
by: Henry H. Balfour, et al.
Published: (2022-08-01)

Inflammatory bowel disease — is there something new in the immunological background?
by: Andrzej Marszałek, et al.
Published: (2011-07-01)

Inflammatory bowel disease &#8212; is there something new in the immunological background?
by: Michał Drews, et al.
Published: (2011-07-01)

Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy
by: Sile Li, et al.
Published: (2022-06-01)

Association of Human Papilloma Virus, Cytomegalovirus, and Epstein–Barr Virus with Breast Cancer in Jordanian Women
by: Ashraf I. Khasawneh, et al.
Published: (2024-04-01)

Evaluation of glycoprotein B genotypes and load of CMV infecting blood leukocytes on prognosis of AIDS patients
by: Aldo Albuquerque Cunha, et al.
Published: (2011-04-01)

Retinitis after haematopoietic stem cell transplantation with multiple intraocular viral infections (cytomegalovirus, Epstein‒Barr virus and herpes simplex virus)- a case report
by: Mengyun Liu, et al.
Published: (2024-01-01)

Congenital CMV Infection: A Complex Case of Neurological Complications and Therapeutic Approaches in Infancy
by: Sylwia Koziej, et al.
Published: (2024-01-01)

EBV CHRONIC INFECTIONS
by: Delia Racciatti, et al.
Published: (2010-02-01)

EBV CHRONIC INFECTIONS
by: Eligio Pizzigallo, et al.
Published: (2010-08-01)

The probable progression of Epstein-Barr virus (EBV) to chronic active EBV/reactivation weakens the immune response and stimulates Cryptococcus neoformans infection, which invariably proves fatal: a case report and review of the literature
by: Gargee Mishra, et al.
Published: (2025-01-01)

EBV-associated diseases: Current therapeutics and emerging technologies
by: Srishti Chakravorty, et al.
Published: (2022-10-01)

Evaluation of Two Different CMV-Immunoglobulin Regimens for Combined CMV Prophylaxis in High-Risk Patients following Lung Transplant
by: Víctor M. Mora, et al.
Published: (2022-12-01)

Exploring health disparities in congenital CMV (cCMV): a study in a Somali-American community to assess awareness of cCMV and facilitate understanding of universal cCMV screening
by: Khadra Hussein, et al.
Published: (2024-03-01)

Human Herpesvirus and the Immune Checkpoint PD-1/PD-L1 Pathway: Disorders and Strategies for Survival
by: Takayuki Murata
Published: (2021-04-01)

The Value of Autoantibody and Viral Serologic Examinations in the Differential Diagnosis of Multiple Sclerosis and Stroke
by: Ahmet, et al.
Published: (2019-12-01)